IL22RA1 and pulmonary fibrosis: The cause and effect of IL‐22 in the protection against pulmonary fibrosis have been established by using an IL‐22R KO mouse model and an IL‐22 protein augmentation model via intranasal instillation of recombinant IL‐22.